Chronic headache education and self-management study (CHESS)

Not Applicable

Completed

• Conditions: Chronic headaches; Signs and Symptoms

• Registration Number: ISRCTN79708100
• Lead Sponsor: niversity of Warwick

Brief Summary

2019 Interim results article in https://www.ncbi.nlm.nih.gov/pubmed/30744571 feasibility results 2019 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/30885120 intervention development (added 20/03/2019) 2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32284387/ main trial protocol (added 15/02/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33942667/ comparative evaluation (added 05/05/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/34796815/ experiences of patient and public involvement (added 31/10/2022) 2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31164158/ process evaluation protocol (added 31/10/2022) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/36609224/ Process evaluation results (added 09/01/2023) 2023 Results article in https://doi.org/10.1212/wnl.0000000000201518 (added 05/09/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38745132/ post-hoc secondary analyses not specified in the original statistical analysis plan (added 20/05/2024) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/39095730/ Qualitative interviews conducted during the CHESS study (added 06/08/2024)

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-16
• Study Completion: 2020-01-04
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 689

Inclusion Criteria

1. Able and willing to comply with the study procedures and provision of written informed consent
2. Aged 18 years or above
3. Living with chronic headache; defined as headache for 15 or more days per month for at least three months.
4. Result of nurse classification interview confirms headache type to be definite or probable chronic migraine, or chronic tension type headache, and/or medication overuse headache
5. Fluent in written and spoken English

Exclusion Criteria

1. Unable to attend treatment programme
2. No access to a telephone
3. Has an underlying serious psychiatric or psychological disorder that precludes participation in the group intervention
4. Known secondary cause of headache other than medication overuse headache; e.g. primary or secondary brain tumour
5. Is currently participating in another clinical trial (with an unregistered medicinal product), or less than 90 days have passed since completing participation in such a trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified